Erratum: The Basis for Weekly Insulin Therapy: Evolving Evidence with Insulin Icodec and Insulin Efsitora Alfa (Endocrine Reviews (2024) DOI: 10.1210/endrev/bnad037)

  • Julio Rosenstock (Lead / Corresponding author)
  • , Rattan Juneja
  • , John M. Beals
  • , Julie S. Moyers
  • , Liza Ilag
  • , Rory McCrimmon

    Research output: Contribution to journalComment/debatepeer-review

    11 Downloads (Pure)

    Abstract

    In the above-named article by Rosenstock J, Juneja R, Beals JM, Moyers JS, Ilag L, and McCrimmon RJ (Endocrine Reviews 2024; doi: 10.1210/endrev/bnad037), there was an error in Figure 10. In the above-mentioned article, the Figure 10A caption read: Schematic depiction of the distribution of efsitora in the different biological compartments over time from initiation of once-weekly dosing (injection 1) through injection 8, showing the gradual movement of insulin icodec from the subcutis through the blood to the intercellular space where build-up occurs. In the corrected articled, insulin icodec has been changed to insulin efsitora and reads as: Schematic depiction of the distribution of efsitora in the different biological compartments over time from initiation of once-weekly dosing (injection 1) through injection 8, showing the gradual movement of insulin efsitora from the subcutis through the blood to the intercellular space where build-up occurs. The article has been corrected online. doi: 10.1210/endrev/bnad037.

    Original languageEnglish
    Pages (from-to)436
    Number of pages1
    JournalEndocrine Reviews
    Volume45
    Issue number3
    Early online date22 Mar 2024
    DOIs
    Publication statusPublished - 1 Jun 2024

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Endocrinology

    Fingerprint

    Dive into the research topics of 'Erratum: The Basis for Weekly Insulin Therapy: Evolving Evidence with Insulin Icodec and Insulin Efsitora Alfa (Endocrine Reviews (2024) DOI: 10.1210/endrev/bnad037)'. Together they form a unique fingerprint.

    Cite this